ESI-08 是 EPAC2 的有效拮抗剂，IC50 为 8.4 μM。 ESI-08 特异性阻断 cAMP 诱导的 EPAC 活化，但不阻断 cAMP 介导的 PKA 活化。

ESI-08 is an effective antagonist of EPAC2 with an IC50 of 8.4 μM. ESI-08 selectively blocks cAMP-induced EPAC activation but not cAMP-mediated PKA activation.

ESI-08 (25 μM) does not alter cAMP-induced type I and II PKA holoenzymes activation while H89, a selective PKA inhibitor, blocked the type I or II PKA activities completely[1].

301177-43-5

C20H23N3OS

353.48

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years